NVS (NVS) Stock Price & Analysis
NVS (NVS) fell 1.90% to USD 159.99 as of September 8, 2026 at 04:19 UTC, according to Nexqual real-time market data.
NVS last closed at USD 159.99; the session ranged USD 159.63–160.93 on volume of 1,266,416 shares. Market capitalization is —, with a 52-week range of USD 121.57–170.46 (NYQ). Source: Nexqual, September 8, 2026 at 04:19 UTC.
Key Statistics (as of September 8, 2026 at 04:19 UTC)
| Price | USD 159.99 |
|---|---|
| Change | ▼ 1.90% (down) |
| Previous Close | USD 159.99 |
| Open | USD 159.99 |
| Day Range | USD 159.63 – 160.93 |
| 52-Week Range | USD 121.57 – 170.46 |
| Volume | 1,266,416 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (NVS)
Nexqual's technical model rates NVS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:19 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.53 (neutral) |
| vs SMA50 | Above (USD 155.62) |
| MACD | 1.51 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNY | Sanofi | USD 44.24 | ▼ 0.52% |
| GSK | GSK plc | USD 49.89 | ▼ 1.09% |
| AZN | AstraZeneca PLC | USD 162.7 | ▲ 0.66% |
| RHHBY | Roche Holding Ltd | USD 54.97 | ▲ 2.12% |
| BMY | Bristol-Myers Squibb Company | USD 66.82 | ▼ 1.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:19 UTC. This page is informational and not investment advice.